Viewing Study NCT05329194


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-01-05 @ 1:32 PM
Study NCT ID: NCT05329194
Status: COMPLETED
Last Update Posted: 2025-10-14
First Post: 2022-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module